Renaissance Technologies - CHINA SXT PHARMACEUTICALS IN ownership

CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 6 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$2
-80.0%
10,540
-69.4%
0.00%
Q1 2023$10
-99.9%
34,500
+59.9%
0.00%
Q3 2022$17,000
-67.3%
21,572
-26.8%
0.00%
Q2 2022$52,00029,4720.00%
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Renaissance Technologies 21,572$17,0000.00%
Hudock, Inc. 300$00.00%
UBS Group AG 7,725$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 45,685$35,0000.00%
HRT FINANCIAL LP 10,870$8,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders